Enhanced expression of aromatase in p53-inactivated mammary epithelial cells

Endocrine-Related Cancer

Volumn 15, Issue 1, 2008, Pages 139-147

  Hoo, Kyun Choi ^a   Sang, Hee Roh ^a   Hyung, Gyoun Kim ^a   Eun, Hee Han ^a   Hye, Gwang Jeong ^a   Keon, Wook Kang ^a  

^a Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; EXON; EXON 5; EXON 6; GENE; GENE EXPRESSION; GENETIC DISORDER; GENETIC TRANSFECTION; MOUSE; NONHUMAN; P53 GENE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPORTER GENE;

ANIMALS; AROMATASE; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE EXPRESSION REGULATION; INTEGRASES; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; PROMOTER REGIONS (GENETICS); SRC-FAMILY KINASES; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 41349115289     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0192     Document Type: Article

References (43)

1. Barthet G, Framery B, Gaven F, Pellissier L, Reiter E, Claeysen S, Bockaert J & Dumuis A 2007 5-Hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling. Molecular Biology of the Cell 18 1979-1991.
2. Brodie A, Lu Q & Nakamura J 1997 Aromatase in the normal breast and breast cancer. Journal of Steroid Biochemistry and Molecular Biology 61 281-286.
3. Cammarota M, Bevilaqua LR, Dunkley PR & Rostas JA 2001 Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mechanism. Journal of Neurochemistry 79 1122-1128.
4. Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML & Ando S 2003 Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. Journal of Biological Chemistry 278 28668-28676.
5. Choi CY, Kim JY, Kim YS, Chung YC, Hahm KS & Jeong HG 2001 Augmentation of macrophage functions by an aqueous extract isolated from Platycodon grandiflorum. Cancer Letters 166 17-25.
6. Clemons M, Danson S & Howell A 2002 Tamoxifen ('Nolvadex'): a review. Cancer Treatment Reviews 28 165-180.
7. Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S & Boyle P 2003 Overview of the main outcomes in breast-cancer prevention trials. Lancet 361 296-300.
8. Deome KB, Faulkin LJ Jr, Bern HA & Blair PB 1959 Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Research 19 515-520.
9. Gelain DP, Cammarota M, Zanotto-Filho A, de Oliveira RB, Dal-Pizzol F, Izquierdo I, Bevilaqua LR & Moreira JC 2006 Retinol induces the ERK1/2-dependent phosphorylation of CREB through a pathway involving the generation of reactive oxygen species in cultured Sertoli cells. Cellular Signalling 18 1685-1694.
10. Ghosh S, Lu Y, Katz A, Hu Y & Li R 2007 Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells. American Journal of Physiology. Endocrinology and Metabolism 292 E246-E252.
11. Hokari R, Lee H, Crawley SC, Yang SC, Gum JR, Miura S & Kim YS 2005 Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1. American Journal of Physiology. Gastrointestinal and Liver Physiology 289 G949-G959.
12. Hu Y, Ghosh S, Amleh A, Yue W, Lu Y, Katz A & Li R 2005 Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression. Oncogene 24 8343-8348.
13. Ito M, Achermann JC & Jameson JL 2000 A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes. Journal of Biological Chemistry 275 31708-31714.
14. Kang KW, Cho IJ, Lee CH & Kim SG 2003 Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz. Journal of National Cancer Institute 95 53-66.
15. Kawasaki Y, Kohno T, Zhuang ZY, Brenner GJ, Wang H, Van Der Meer C, Befort K, Woolf CJ & Ji RR 2004 Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. Journal of Neuroscience 24 8310-8321.
16. Kijima I, Phung S, Hur G, Kwok SL & Chen S 2006 Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Research 66 5960-5967.
17. Kinoshita Y & Chen S 2003 Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Research 63 3546-3555.
18. Kirma N, Gill K, Mandava U & Tekmal RR 2001 Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Cancer Research 61 1910-1918.
19. Koberle D & Thurlimann B 2005 Adjuvant endocrine therapy in postmenopausal breast cancer patients. Breast 14 446-451.
20. Levine AJ, Momand J & Finlay CA 1991 The p53 tumour suppressor gene. Nature 351 453-456.
21. Lin SC, Lee KF, Nikitin AY, Hilsenbeck SG, Cardiff RD, Li A, Kang KW, Frank SA, Lee WH & Lee EY 2004 Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Research 64 3525-3532.
22. Lo HW & Ali-Osman F 2002 Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation. Journal of Cellular Biochemistry 87 103-116.
23. Lu M, Chen D, Lin Z, Reierstad S, Trauernicht AM, Boyer TG & Bulun SE 2006 BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells. Journal of Clinical Endocrinology and Metabolism 91 4514-4519.
24. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA et al. 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250 1233-1238.
25. Mann GB & Borgen PI 1998 Breast cancer genes and the surgeon. Journal of Surgical Oncology 67 267-274.
26. Means GD, Kilgore MW, Mahendroo MS, Mendelson CR & Simpson E 1991 Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Molecular Endocrinology 5 2005-2013.
27. Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H & Van der Zee AG 2001 Tamoxifen treatment and gynecologic side effects: a review. Obstetrics and Gynecology 97 855-866.
28. Mueller SO, Clark JA, Myers PH & Korach KS 2002 Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology 143 2357-2365.
29. Pal S, Datta K & Mukhopadhyay D 2001 Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Research 61 6952-6957.
30. Petrangeli E, Lubrano C, Ortolani F, Ravenna L, Vacca A, Sciacchitano S, Frati L & Gulino A 1994 Estrogen receptors: new perspectives in breast cancer management. Journal of Steroid Biochemistry and Molecular Biology 49 327-331.
31. 2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. Journal of Clinical Endocrinology and Metabolism 88 2810-2816.
32. Shozu M, Zhao Y & Simpson ER 2000 TGF-beta1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and THP-1 cells. Molecular and Cellular Endocrinology 160 123-133.
33. Simpson ER 2003 Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology 86 225-230.
34. Simpson ER & Zhao Y 1996 Estrogen biosynthesis in adipose. Significance in breast cancer development. Annals of the New York Academy of Sciences 784 18-26.
35. Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L & Bergh J 1996 The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. Journal of National Cancer Institute 88 173-182.
36. Smith IE & Dowsett M 2003 Aromatase inhibitors in breast cancer. New England Journal of Medicine 384 2432-2442.
37. Srivastava S, Zou ZQ, Pirollo K, Blattner W & Chang EH 1990 Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348 747-749.
38. Treisman R 1996 Regulation of transcription by MAP kinase cascades. Current Opinion in Cell Biology 8 205-215.
39. Utsumi T, Harada N, Maruta M & Takagi Y 1996 Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. Journal of Clinical Endocrinology and Metabolism 81 2344-2349.
40. Vousden KH & Lu X 2002 Live or let die: the cell's response to p53. Nature Reviews. Cancer 2 594-604.
41. 2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135 59-72.
42. Yang JW, Lee EY & Kang KW 2006 ErbB2 overexpression in p53-inactivated mammary epithelial cells. FEBS Letters 580 6501-6508.
43. Young M & MacPhaul MJ 1998 A steroidogenic factor-1-binding site and cyclic adenosine 3′,5′-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines. Endocrinology 139 5082-5093.